http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02215718-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2de3beee83d9c19278da409b72c777a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_065fe7c4146d471ac47823ff7c1d911f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f490aca33d5210f61ffb568097d7c72b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38dbd2c56bcc1975b2ef59968cda92d2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate | 1989-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f9518599a3021072c6a18168f7f901c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91b450e9809edd08c122b2eb4be50705 |
| publicationDate | 1990-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H02215718-A |
| titleOfInvention | Drug containing 4-(1-imidazolylmethyl)cinnamic acid as active ingredient |
| abstract | PURPOSE: To obtain an active oxygen production suppressing agent containing 4-(1-imidazolylmethyl)cinnamic acids as an active ingredient, having action capable of suppressing production of active oxygen in vivo and production of methylguanidine and useful for suppression of occurrence of cancer and delay of progress of renal insufficiency, etc. n CONSTITUTION: The aimed drug contains a compound expressed by the formula and nontoxic salt thereof, acid addition salt thereof and hydrate thereof. When the drug is used for prevention and treatment for various diseases originated in production of active oxygen, the drug is normally systemically or locally administered in oral or parenteral method. The drug is normally administered orally in a dose of 10-200mg/adult day or intravenously in a dose of 1-1000mg/ adult day, through the dose is different from age, weight, symptoms, treating effects administration method. n COPYRIGHT: (C)1990,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0656669-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07188024-A |
| priorityDate | 1989-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.